Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown PrimaryCLINICAL CHEMISTRYIF6.32024-01-042PRE
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trialNATURE COMMUNICATIONSIF15.72023-10-2416OAAI
Frequency and prognostic value of circulating tumor cells in cancer of unknown primaryANNALS OF ONCOLOGYIF65.42023-10-010PRE
Human SLFN5 and its Xenopus Laevis ortholog regulate entry into mitosis and oocyte meiotic resumptionCELL DEATH DISCOVERYIF72022-12-081OAAI
Combined ipilimumab and nivolumab in previously treated patients with cancer of unknown primary: Results of the CheCUP trialANNALS OF ONCOLOGYIF65.42022-09-011PRE
Prognostic impact of copy number alterations and tumor mutational burden in carcinoma of unknown primaryGENES CHROMOSOMES & CANCERIF2.82022-04-308PRE
Local ablative treatment with surgery and/or radiotherapy in single-site and oligometastatic carcinoma of unknown primaryEUROPEAN JOURNAL OF CANCERIF7.12021-11-0114PREAI
SMC3 protein levels impact on karyotype and outcome in acute myeloid leukemiaLEUKEMIAIF13.42018-10-157PREAI
Wnt-11 and Fz7 reduce cell adhesion in convergent extension by sequestration of PAPC and C-cadherinJOURNAL OF CELL BIOLOGYIF6.42012-08-2061OAAI
The Extracellular Domain of Lrp5/6 Inhibits Noncanonical Wnt Signaling In VivoMOLECULAR BIOLOGY OF THE CELLIF2.72009-02-01116OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向